Insights

A2 Milk and Mesoblast were among the most traded shares on the ASX last week

A2 Milk Company Ltd (ASX:A2M) and Mesoblast limited (ASX:MSB) shares were among the most traded shares on the CommSec platform last week.
The post A2 Milk and Mesoblast were among the most traded shares on the ASX last week appeared first on Motley Fool Australia. –

Financial Technology

This morning Australia’s leading investment platform provider CommSec released data on the most traded ASX shares on its platform from last week.

A number of familiar faces have made it into the top five again this week, with one company far and away the most traded share on the platform.

Here’s the data:

Mesoblast limited (ASX: MSB)

Mesoblast shares were easily the most traded shares on the CommSec platform last week and accounted for 5.6% of total trades. And while a sizeable 75% of these trades came from buyers, it wasn’t enough to stop the Mesoblast share price from losing 35% of its value. An unfavourable decision by the US FDA led to the share price weakness.

A2 Milk Company Ltd (ASX: A2M)

This infant formula company’s shares were popular with retail investors last week and were responsible for 2.6% of total trades on the platform. It appears as though investors were taking advantage of an 18.5% decline in the a2 Milk share price following a disappointing trading update to pick up shares. Approximately 83% of these trades came from buyers.

BrainChip Holdings Ltd (ASX: BRN)

This artificial intelligence technology company’s shares are in the top five again. BrainChip shares accounted for 2.4% of trades on the CommSec platform last week, with 62% coming from buyers. This buying support couldn’t stop the BrainChip share price from losing almost 23% of its value over the five days.

Zip Co Ltd (ASX: Z1P)

Investors were trading this buy now pay later provider’s shares in large numbers last week. Approximately 2.2% of trades on the CommSec platform were attributable to Zip’s shares. And although the company’s shares rose almost 9% during the week, just 38% of these trades came from the buy side.

Flight Centre Travel Group Ltd (ASX: FLT)

Finally, reductions in COVID-19 numbers in Victoria and news that a travel bubble would soon be opening between Australia and New Zealand gave the travel sector a boost last week. This led to Flight Centre shares accounting for 1.8% of trades on the CommSec platform. Buyers accounted for 56% of these trades, helping drive its shares 6% higher for the week.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool Australia has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post A2 Milk and Mesoblast were among the most traded shares on the ASX last week appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!